| AWSHX | JVLIX | AWSHX / JVLIX | |
| Total Expense Ratio | 0.55 | 0.71 | 77% |
| Annual Report Gross Expense Ratio | 0.55 | 0.72 | 76% |
| Fund Existence | 74 years | 30 years | - |
| Gain YTD | 4.890 | 18.285 | 27% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 250 | 250000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 219B | 19.5B | 1,123% |
| Annual Yield % from dividends | 1.20 | 0.69 | 175% |
| Returns for 1 year | 6.76 | 21.81 | 31% |
| Returns for 3 years | 27.11 | 32.55 | 83% |
| Returns for 5 years | 27.56 | 20.65 | 133% |
| Returns for 10 years | 78.71 | 77.53 | 102% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| HNVRX | 54.96 | 0.41 | +0.75% |
| Harbor Small Cap Value Retirement | |||
| DESGX | 29.05 | 0.10 | +0.35% |
| DWS Enhanced Core Equity Institutional | |||
| ALMRX | 29.61 | 0.07 | +0.24% |
| Alger Mid Cap Growth Institutional I | |||
| IAXIX | 11.21 | -0.03 | -0.27% |
| VY® T. Rowe Price Divers Mid Cap Gr I | |||
| PRHSX | 89.67 | -1.08 | -1.19% |
| T. Rowe Price Health Sciences | |||